The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: The GenePD study

Authors

Jeanne C. Latourelle, Boston University
Mei Sun, Harvard University
Mark F. Lew, University of Southern California
Oksana Suchowersky, University of Calgary
Christine Klein, Medical University of LuebeckFollow
Lawrence I. Golbe, University of Medicine and Dentistry of New JerseyFollow
Margery H. Mark, University of Medicine and Dentistry of New JerseyFollow
John H. Growdon, Harvard UniversityFollow
G Frederick Wooten, University of Virginia Health System
Ray L. Watts, University of Alabama - Birmingham
Mark Guttman, University of Toronto
Brad A. Racette, Washington University School of Medicine in St. Louis
Joel S. Perlmutter, Washington University School of Medicine in St. Louis
Anwar Ahmed, Barrow Neurological Institute
Holly A. Shill, Sun Health Research Institute
Carlos Singer, University of Miami
Stefano Goldwurm, Instituti Clinici di Perfezionamento
Gianni Pezzoli, Instituti Clinici di Perfezionamento
Michela Zini, Instituti Clinici di Perfezionamento
Marie H. Saint-Hilaire, Boston University
Audrey E. Hendricks, Boston University
Sally Williamson, Boston University
Michael W. Nagle, Boston University
Jemma B. Wilk, Boston University
Tiffany Massood, Boston University
Karen W. Huskey, Boston University
Jason M. Laramie, Boston University
Anita L. DeStefano, Boston University
Kenneth B. Baker, Cleveland Clinic Foundation
Ilia Itin, Cleveland Clinic Foundation
Irene Litvan, University of Louisville
Garth Nicholson, University of Sydney
Alastair Corbett, University of Sydney
Martha Nance, Park Nicollet Clinic
Edward Drasby, Port City Neurology
Stuart Isaacson, Parkinson's Disease and Movement Disorder Center of Boca Raton
David J. Burn, Newcastle University
Patrick F. Chinnery, Newcastle University
Peter P. Pramstaller, General Regional Hospital Bolzano
Jomana Al-hinti, University of Arkansas - Medical Sciences
Anette T. Moller, Aarhus University
Karen Ostergaard, Aarhus University
Scott J. Sherman, University of Arizona
Richard Roxburgh, Auckland City Hospital
Barry Snow, Auckland City Hospital
John T. Slevin, University of Kentucky
Franca Cambi, University of Kentucky
James F. Gusella, Harvard University
Richard H. Myers, Boston University

Journal

BMC Medicine

Publication Date

2008

Volume

6

Inclusive Pages

32

Document Type

Open Access Publication

Rights and Permissions

BMC Medicine 2008, 6:32 http://www.biomedcentral.com/1741-7015/6/32 © 2008 Latourelle et al; licensee BioMed Central Ltd.

Recommended Citation

Latourelle, Jeanne C.; Sun, Mei; Lew, Mark F.; Suchowersky, Oksana; Klein, Christine; Golbe, Lawrence I.; Mark, Margery H.; Growdon, John H.; Wooten, G Frederick; Watts, Ray L.; Guttman, Mark; Racette, Brad A.; Perlmutter, Joel S.; Ahmed, Anwar; Shill, Holly A.; Singer, Carlos; Goldwurm, Stefano; Pezzoli, Gianni; Zini, Michela; Saint-Hilaire, Marie H.; Hendricks, Audrey E.; Williamson, Sally; Nagle, Michael W.; Wilk, Jemma B.; Massood, Tiffany; Huskey, Karen W.; Laramie, Jason M.; DeStefano, Anita L.; Baker, Kenneth B.; Itin, Ilia; Litvan, Irene; Nicholson, Garth; Corbett, Alastair; Nance, Martha; Drasby, Edward; Isaacson, Stuart; Burn, David J.; Chinnery, Patrick F.; Pramstaller, Peter P.; Al-hinti, Jomana; Moller, Anette T.; Ostergaard, Karen; Sherman, Scott J.; Roxburgh, Richard; Snow, Barry; Slevin, John T.; Cambi, Franca; Gusella, James F.; and Myers, Richard H., "The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: The GenePD study." BMC Medicine. 6, 32. (2008).
https://digitalcommons.wustl.edu/open_access_pubs/278